ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Funding Opportunities.

April 5, 2002

Former kidney cancer advocate Carl Dixon charged with theft of $335,000 from association.

October 3, 2003

Data On CT Screening For Lung Cancer Raises Questions About DOD Program

April 23, 2010

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009